Sejong, South Korea

Kyubeen Park

This inventor holds 2 USPTO granted patents. Top assignees: Carboexpert Inc., The Industry & Academic Cooperation in Chungnam National University (Iac). Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kyubeen Park. Retrieved from https://idiyas.com/inventor/kyubeen-park

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kyubeen Park: Innovator in Pharmaceutical Chemistry

Introduction

Kyubeen Park is a notable inventor based in Sejong, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of prodrugs for therapeutic applications. His innovative work focuses on enhancing drug solubility and stability, which is crucial for effective treatment.

Latest Patents

Kyubeen Park holds a patent for an ester derivative prodrug of inotodiol. This prodrug not only exhibits increased solubility in both inorganic and organic solvents but also demonstrates improved stability. The invention is particularly relevant for the treatment of various inflammatory and allergic diseases, showcasing its potential impact on healthcare.

Career Highlights

Throughout his career, Kyubeen Park has worked with several organizations, including Carboexpert Inc. and the Industry & Academic Cooperation in Chungnam National University. His experience in these institutions has allowed him to collaborate with other professionals and contribute to advancements in pharmaceutical research.

Collaborations

Some of Kyubeen Park's notable coworkers include Jongtae Park and Phu Cuong Nguyen. Their collaborative efforts have likely played a role in the successful development of innovative solutions in the pharmaceutical field.

Conclusion

Kyubeen Park's contributions to pharmaceutical chemistry, particularly through his patent on an ester derivative prodrug, highlight his role as an innovator in the industry. His work has the potential to improve treatment options for patients suffering from inflammatory and allergic diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…